Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market…

The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing,…

The chairman and CEO of Santa Farma discusses how the Turkish pharmaceutical landscape has evolved in response to the government’s healthcare…

The managing director at Adcock Ingram Critical Care reveals the company's unique business model. As a long-established division within Adcock…

One of the directors of Romania's number one producer of suppositories and the only in-country manufacturer of contraceptive ovules speaks out about…

The CEO of Centurion shares his ambitious vision for the company's expansion into plasma products, biotech, orphan drugs, and generic injectables…

Keyman’s general manager discusses his firm’s development efforts towards vaccine production, in conjunction with TUBITAK and Hacettepe…

Imuneks is currently operating in the OTC market, but with three supergeneric products ready to market on the RX side, the firm has the potential to…

George Cretu, founder of Enterprise Concept in Bucharest discusses how his past work experience in the United States inspired him to start his unique…

“When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a…